Clinical Trial Update: Inhibition of Aldosterone in Patients With Chronic Renal Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing aldosterone inhibition in patients with chronic kidney disease has completed; the update summarizes the trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: Lene Boesby | Conditions: Kidney Failure, Chronic | Phase 4 | Status: COMPLETED